Share-based compensation
expenses 7,013 3,827
-------------------- -------------------
Adjusted operating loss (24,063) (34,485)
-------------------- -------------------
Net loss (29,822) (38,907)
Share-based compensation
expenses 7,013 3,827
Income tax (benefits)/expenses (5,205) 119
Interest income (2,264) (2,901)
Interest expense 5,314 4,105
Adjusted EBIT (24,964) (33,757)
-------------------- -------------------
Net loss attributable to Zepp
Health Corporation (29,741) (38,857)
Share-based compensation
expenses 7,013 3,827
-------------------- -------------------
Adjusted net loss attributable
to Zepp Health Corporation([)
(2]) (22,728) (35,030)
==================== ===================
Adjusted net loss per share
attributable to Zepp Health
Corporation
Adjusted basic loss per
ordinary share (0.09) (0.14)
Adjusted diluted loss per
ordinary share (0.09) (0.14)
Adjusted net loss per ADS (16
ordinary shares equal to
1 ADS)([3])
ADS -- basic (1.49) (2.16)
ADS -- diluted (1.49) (2.16)
Weighted average number of
shares used in computing
adjusted net loss per share
Ordinary share -- basic 243,679,883 259,433,512
Ordinary share -- diluted 243,679,883 259,433,512
Share-based compensation
expenses included are
follows:
Selling and marketing 497 368
General and administrative 3,154 1,812
Research and development 3,362 1,647
-------------------- -------------------
Total 7,013 3,827
-------------------- -------------------
View original content:https://www.prnewswire.com/news-releases/zepp-health-corporation-reports-third-quarter-2024-unaudited-financial-results-302308549.html
SOURCE Zepp Health Corp.
(END) Dow Jones Newswires
November 18, 2024 20:00 ET (01:00 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.